Background {#S0001}
==========

Tuberculosis (TB) is caused by *Mycobacterium tuberculosis*, and mainly affects the lungs. TB remains a serious public health challenge throughout the world, most notably in low- and middle-income countries, ranking above HIV/AIDS.[@CIT0001] Globally, around 10.4 million people fell ill with TB and 1.7 million died from the disease in 2016. The dynamics of transmission vary geographically, with the largest number of new TB cases occurring in Asia and Africa: 45% and 25% respectively.[@CIT0002],[@CIT0003]

The association of TB and diabetes mellitus (DM) is a concern for health sectors, as the coexistence of these two highly prevalent diseases has made -existing treatments very complex.[@CIT0004] The link between TB and DM is considered more prominent in developing countries, where TB is endemic and the burden of DM increasing. Accordingly, it is estimated that about 1.6 million deaths were directly caused by DM ---which is 1.69 times more likely to develop into TB than among non-DM individuals --- in 2015.[@CIT0005],[@CIT0006]

Currently, the worldwide prevalence of DM is increasing more quickly than ever (11.7%), which increases TB and makes existing treatments very complex among the coinfected patients.[@CIT0007] The prevalence of DM and the incidence of TB in Ethiopia have been found to be 6.5% and 164 per 100,000 population, respectively.[@CIT0001],[@CIT0008] However, evidence suggests that about a third of TB patients initiate care and are referred to health-care facilities with health-extension workers.[@CIT0009] Even though different interventions have been made by the government, TB incidence in Ethiopia remains high. Therefore, this retrospective cohort study was conducted to identify risk factors of TB among diabetic patients at Debre Markos Referral Hospital, northwest Ethiopia.

Methods {#S0002}
=======

Study Design and Setting {#S0002-S2001}
------------------------

This institutionally based retrospective cohort study was undertaken between January 2013 to December 2017 in the chronic-care follow-up care unit of Debre Markos Referral Hospital. Debre Markos is located 300 km from Addis Ababa, the capital of Ethiopia, and 256 km from Bahir-Dar, the capital of Amhara Regional State. Debre Markos Referral Hospital is the only referral hospital found in East Gojjam Zone, and serves \>3.5 million people in its catchment area. Aso, the hospital provides diabetic care services. After submission of the research proposal and getting approval from the Debre Markos university Health Science College ethical review committee (Res/Com/ser/&Post gra/Coor/Off: 781/11/10) the study was conducted.

Population {#S0002-S2002}
----------

The study population for this study were all adult (≥18 years old) diabetic patients registered with Debre Markos Referral Hospital for chronic follow-up care from January 1, 2013 to December 30, 2017.

Inclusion and Exclusion Criteria {#S0002-S2003}
--------------------------------

All diabetic patients who fulfilled the inclusion criteria of being registered adult diabetic patients from January 1, 2013 to December 30, 2017 in the chronic-care follow-up clinic of Debre Markos Referral Hospital were included in the study. However, we excluded diabetic patients with gestational DM, incomplete data or unavailable medical records, had been transferred in and who had had TB at the time of DM diagnosis.

Data-Collection Procedures {#S0002-S2004}
--------------------------

A 5-year institution-based retrospective follow-up study was conducted using chart review at Debre Markos Referral Hospital chronic-care follow up clinic on adult diabetic patients who had been registered from January 1, 2013 to December 30, 2017. All eligible patients were included in the study (census method) after ethical clearance had been obtained from the Institutional Review Committee of the College of Health Sciences, Debre Markos University (Res/Com/ser/&Post gra/Coor/Off: 781/11/10), and verbal informed consent was obtained from the patients. Medical record number of patients were obtained from electronic database and health management information--system registry books that had been used for the routine care of DM from January 1, 2013 to December 30, 2017. Then, by using the record numbers of the patients, their medical records were identified and their status assessed for the development of TB starting from diabetic follow-up initiation (first follow-up visit) to the end of the study using validated data-collection checklists.

Variables {#S0002-S2005}
---------

The dependent variable for this study was incidence of TB among diabetic patients. Independent variables were socio-demographic factors (age, sex, and residence), personal behaviors (smoking, alcohol use, and both smoking and alcohol use), and clinical characteristics (type of DM, BMI, duration of DM, glycemic control, anti-DM medications, history of TB treatment, close contact with TB patients, and history of renal failure).

Data Analysis {#S0002-S2006}
-------------

Data collection--checklist tools adapted from a previous study in Ethiopia were used for data collection.[@CIT0010] We used EpiData Version 3.1 for data entry and Stata version 14 for data analysis. The necessary assumption of the Cox proportional-hazard regression model was checked using the Schönfeld residual test and log--log plots. Diabetic cohort characteristics of continuous data were described in terms of central tendency (mean or median), dispersion (SD or IQR) and frequency distribution for categorical data. Finally, outcomes of diabetic patients were dichotomized into censored or event categories. Kaplan--Meier survival curves were used to estimate survival time, and log-rank tests to compare survival curves. Bivariate Cox proportional-hazard regression was fitted for each explanatory variable, and those with *P*≤0.25 in bivariate analysis were fitted to the multivariate Cox proportional-hazard regression model. HRs with 95% CIs and *P*-values were used to measure the strength of association and identify statistically significant predictors. In multivariat analyses, variables with *P*\<0.05 were considered significant predictors of TB.

Results {#S0003}
=======

Sociodemographic Characteristics of Study Participants {#S0003-S2001}
------------------------------------------------------

In this retrospective cohort study, 433 diabetic patients at Debre Markos Referral Hospital from January 1, 2013 to December 30, 2017 were included. [Figure 1](#F0001){ref-type="fig"}. Nearly half 187 43.2%) the patients were aged \<18 years. The median age of patients was 39 (18--79 years). In addition, about 241 (55.7%) participants were male and 270 (62.5%) rural residents.Figure 1Kaplan--Meier curve of tuberculosis survival for diabetic patients at Debre Markos Referral Hospital from January 01, 2013 to December 30, 2017

Clinical and Behavioral Characteristics of Patients {#S0003-S2002}
---------------------------------------------------

This study revealed that about 33 (7.6%) patients were positive for HIV and 34 (7.9%) had a history of renal failure. The duration of DM in all patients varied from date of initiation to 5 years of follow-up. A toal of 53 (12.2%) participants had a family history of DM, and 224 (51.7%) had type 1 DM. About 197 (45.5%) patients were on oral hypoglycemic agents, and 362 (83.6%) were normal and overweight. About eight (1.9%) were smokers, 16 (3.7%) had a history of alcohol consumption, and only five (1.2%) had a history of both alcohol consumption and smoking ([Table 1](#T0001){ref-type="table"}).Table 1Baseline Sociodemographic, Clinical, and Behavioral Characteristics of People Living with Diabetes at Debre Markos Referral Hospital from January 1, 2013 to December 30, 2017CharacteristicsnPercentagePYsTBTBID**Sex**Male24155.755.7150.27Female19244.344.3110.25**Age, years**18--3518743.2489.9140.0336--5015736.3385.290.02\>508920.6226.430.02Median39.9**Place of residence**Urban16337.6441.3100.02Rural27062.4660.2160.02**BMI (kg/m^2^)**\<18.57116.4212.5130.06≥18.536283.6889130.01**HIV serostatus**Positive337.679.430.04Negative40092.41,022.1230.02**Type of DM**Type I22451.7593.1190.03Type II20948.3508.470.01**Blood-glucose level (mg/dL)**≤70143.24710.0270--13016538.1417.380.02≥13025458.7637.2170.03**History of TB**Yes92.123.550.21No42497.91,078210.02**History of close contact**Yes51.11030.3No42898.81,091.520.15**Duration of TB since DM diagnosis**≤1year1246.227120.441--3 year1453.963.5140.22**DM medications had been/being used**OHA19745.5492.360.01Insulin22652.2580180.03Both OHA and insulin102.329.220.07**History of smoking**Yes81.92210.05No42598.21,079.5250.02**History of alcohol**Yes163.74750.11No41796.31,054.5210.02**History of both smoking and alcohol**Yes51.21000No42898.91,091.5260.02[^1]

Incidence of Tuberculosis among Diabetic Patients {#S0003-S2003}
-------------------------------------------------

Patients were followed for a total of 1,101.5 person years (PYs). The mean, median, and range of follow-up were 2.5, 2, and 4.8 years with (IQR 3), respectively. During follow-up, 26 (6%) patients were new TB cases (events). The overall incidence-rate ratio of TB was found to be 2.4 per 100 PYs with 95% confidence. Among the 26 individuals reporting TB, 15 (57.7%) were male and 20 (76.9%) had pulmonary TB. Of these 20 (76.9%) with pulmonary TB, only four (20%) had a history of TB. Moreover, a relatively higher proportion of TB patients 14 (53.6%) were aged 18--35 years. In addition, incidence was higher among rural residents (16, 61.5%) and those that had 1--3 years\' (14, (53.8%) follow-up. More than half 19 (73.1%) TB + DM patients had type 1 DM.

Tuberculosis-Incidence Density {#S0003-S2004}
------------------------------

In this study, 433 participants were followed for different periods over 5 years, producing 1,101.5 PYs of observation. The mean, median, and range of follow-up time were 2.5, 2, and 4.8 years (IQR=3), respectively. Within follow-up, 26 patients were found to have post-DM TB (new cases), with an overall TB incidence density of 2.4 per 100 PYs with 95% confidence ([Table 2](#T0002){ref-type="table"}, [Figures 2](#F0002){ref-type="fig"}--[4](#F0004){ref-type="fig"}).Table 2Tuberculosis Incidence Density Rate Stratified by Sociodemographic, Clinical, and Behavioral Characteristics of Diabetic Patients at Debre Markos Referral Hospital from January 1, 2013 to December 30, 2017FrequencyPYsTBTB IDRCrude HR (95% CI)Adjusted HR (95% CI)*P*-value**Sex** Male24155.7150.271.8 (1.2--3.2) Female19244.3110.251.0**Age, years** 18--35187489.9140.03 36--50157385.290.02 \>5089226.430.02**Place of residence** Urban163441.3100.021 Rural270660.2160.020.72 (0.04--11)**Clinical characteristicsHIV serostatus** Positive3379.430.041 Negative4001022.1230.020.52 (0.15--1.7)0.32**History of renal failure** Yes3478.120.00210.99 No3991023240.021.1 (0.24--4.3)**Family history of DM** Yes5389.440.0031 No3801,011.7220.021.1 (0.35--3)0.96**Type of DM** Type I224593.1190.0311 Type II209508.470.010.4 (0.2--1)1.6 (0.29--8.4)0.24**BMI (kg/m^2^)** \<18.571212.5130.0611 ≥18.5362889130.010.2 (0.1--0.6)0.34 (0.14--0.8)0.03**Blood-glucose level (g/dL)** \<70144710.021 70--130165417.380.021.1 (0.12--8.1)0.99 ≥130254637.2170.031**History of TB** Yes923.550.2124 (6.6--52)12 (3--39)0.01 No4241,078210.0211**History of close contact with TB** Yes51030.3 No4281,091.520.15**Duration of TB since DM diagnosis** ≤1year1227120.441 1--3 years1463.5140.220.4 (0.2--1.1)**DM medications** OHGAs197492.360.011 Insulin226580180.032.7 (1.1--6)2.8 (0.46--16)0.26 OHA + insulin1029.220.078 (0.8--54)6 (0.8--46)0.08**BMI (kg/m^2^)** \<18.571212.5130.0611 ≥18.5362889130.010.2 (0.13--0.6)0.34 (0.1--0.8)0.03**Behavioral characteristicsHistory of smoking** Yes82210.051 No4251,079.5250.020.6 (0.1--4.3)**History of alcohol** Yes164750.118.5 (1.4--11)4 (1.2--13)0.02 No4171,054.5210.0211**History of smoking and alcohol** Yes51000 No4281,091.5260.02[^2] Figure 2Kaplan--Meier survival curves comparing tuberculosis-free survival probability of diabetic patients based onr body-mass index.Figure 3Kaplan--Meier survival curves comparing tuberculosis-free survival probability of diabetic patients based on their history of tuberculosis.Figure 4Kaplan--Meier survival curves comparing tuberculosis-free survival probability of diabetic patients based on their history of alcohol consumption.

Predictors of Time to TB Occurrence among Diabetic Patients {#S0003-S2005}
-----------------------------------------------------------

On bivariate Cox regression analysis, significant predictors (*P*≤0.25) of TB included HIV serostatus, history of renal failure, family history of DM, blood-glucose level, BMI, type of DM, diabetic medication, history of TB and history of alcohol consumption. To determine independent predictors of TB, a multivariate Cox proportional adjusted hazard model was fitted after the proportional hazard assumption had been checked with a global test (0.94), log-rank test for significantly associated variables on multivariate analysis (BMI 0.02, history of TB 0.001, history of alcohol consumption 0.001), and by graphic assessment. Finally, only history of alcohol consumption, history of TB, and BMI remained significant predictors of TB (*P*\<0.05). Accordingly, those with DM who had a history of alcohol consumption had four times the risk of developing TBcompared to those who had no history of alcohol consumption (incidencerate ratio (4, 95% CI 1.2, 13); P=0.02)) and patients who had a history of TB had 12 times the risk of developing TB compared to those who had no history of TB (incidence-rate ratio 12, 95% CI 3,39; *P*=0.01). Conversely, patients who were normal and overweight (BMI ≥18.5 kg/m^2^) were less likely to develop TB (incidence-rate ratio 0.34. 95% CI 0.14--0.80; *P*=0.03) than their underweight (\<18.5 kg/m^2^) counterparts.

Discussion {#S0004}
==========

Despite numerous interventions to prevent TB, it remains a serious global public health concern, especially in low- and middle-income countries. Therefore, we conducted this retrospective cohort study to determine the incidence of TB among diabetic patients at Debre Markos Referral Hospital, Ethiopia. The overall incidence rate of TB at Debre Markos Referral Hospital was found to be 2.4 per 100 PYs with 95% confidencew among diabetic patients. Our figure is higher than results of a number of studies conducted in Texas (0.31 per 100PYs), China (0.30 per 100PYs, 0.22 per 100PYs), and Tanzania (1.7 per 100 PYs).[@CIT0011]--[@CIT0013] These variations among studies could be explained in part by differences in sample size, study settings, follow-up periods, and sociodemographic characteristics of study participants. In addition, the distinction might be the use of sophisticated screening and diagnostic techniques for early testing and detection prior to disease progression in developed countries like the US and China. This is supported by other studies showing that sophisticated screening and diagnostic techniques for early testing and detection reduced the incidence of TB disease.[@CIT0007],[@CIT0014]

Though the findings of this study are consistent with a study conducted in India (2.2 per 100 PYs),[@CIT0015] they are inconsistent with one in north India (0.655 per 100 PYs).[@CIT0016] This might be due to differences in population and study layout (a prospective study was conducted on patients with type 2 DM) in north India, which had relatively decent insulin secretion and glycemic control that prevented the development of complications and coinfections compared to type 1 DM. Conversely, our finding is much lower than the TB incidence reported in Australia (5.8 per 100 PYs) and Ethiopia (Black Lion \[ 3.8 per 100PYs\][@CIT0017] and Dessie \[6.2 per 100PYs\] referral hospitals[@CIT0018]). In the same way, these variations among studies could be explained in part by differences in sample size, study settings, follow-up periods, and sociodemographic characteristics of study participants. In this study, nearly half (48%) the respondents had type 2 DM, which is more common in advanced ages with minimal complications, including TB, because of relatively decent insulin secretion for glycemic control.[@CIT0011] In addition, most respondents in this study were rural residents, and so socioeconomic and demographic factors, such as problems in getting to the health-care organization, may have played a part.

In this cohort study, a history of alcohol consumption was significantly associated with TB. Accordingly, patients with a history of alcohol consumption were four times as likely to develop TB than patients with no history of TB(incidence-rate ratio 4, 95% CI 1.2--13; *P*=0.02). This is consistent with studies in Texas,[@CIT0019] Australia,[@CIT0020] India,[@CIT0021] and Ethiopia.[@CIT0022] However, this study contradicts findings reported from US,[@CIT0023] UK [@CIT0024] and China.[@CIT0025] Variations among studies could be attributable to differences in sample size, study settings, follow-up periods, and sociodemographic characteristics of study participants.

Furthermore, one of the most significant predictors of TB among diabetic patients was a history of TB. Accordingly, patients with a history of TB were 12 times as likely to develop TB than their counter parts (incidence-rate ratio 12, (95% CI 3--39); *P*=0.01), which is consistent with a study conducted in Australia[@CIT0020] and studies in Ethiopia.[@CIT0017],[@CIT0018],[@CIT0022] In addition, our study demonstrated that patients with BMI ≥18.5 kg/m^2^ were at higher risk of TB than their counterparts (BMI \<18.5 kg/m^2^, incidence-rate ratio 0.34, 95% CI 0.14--0.80;  *P*=0.03), which aligns with previous studies conducted in southeastern Amhara,[@CIT0026] Ethiopia (systematic review),[@CIT0022] Egypt,[@CIT0027] the US,[@CIT0023],[@CIT0028] and China (adjusted HR 0.89, 95% CI 0.76--1.03).[@CIT0025]

Conversely, this study\'s findings contradict those of the study conducted in Ethiopia at Black Lion hospital.[@CIT0010] This could be due to difference in sociodemographic characteristics as more than half the respondents in this study were rural residents and underweight. It is known that most commonly, underweight patients are considered immunocompromised to withstand TB infection. In addition, most respondents in this study were rural residents, so suchproblems as getting to the health -care organization, may have played a part.

Limitations {#S0005}
===========

The main strength of this study is it was conducted using retrospective cohort design. Therefore, we were able to include a range of sociodemographic, clinical, and behavioral factors, which were very important in determining seroconversion. Despite these strengths, this study has a number of limitations. Firstly, it was conducted at a hospital; therefore, diabetic patients at home could have been missed. Moreover secondary data were used, and consequently some important variables, such as a history of cancer, chemotherapy, adherence status, glycated hemoglobin, and organ transplantation, might have been missed. Furthermore, the impact of provider training, supplies, equipment, and setup were notexplored.

Conclusion {#S0006}
==========

In this 5-year diabetic cohort, the overall incidence of TB was high. Pulmonary TB accounted for the highest proportion. History of alcohol consumption and history of TB were found to be independent predictors of TB, but being normal and overweight (BMI ≥18.5 kg/m^2^) was found to be an independent positive factor associated with decreased risk of TB occurrence. Special attention should be given patients who have a history of alcohol consumption, history of TB, and low BMI to reduce the risk of TB incidence by improving modifiable risk factors. All diabetic patients should be screened for TB in clinical practice to prevent the occurrence of TB as early as possible. Furthermore, a prospective cohort study should be conducted to clarify relationships between predictors and TB incidence among diabetic patients.
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